Nancy L. Kuntz, MD

Attending Physician, Division of Neurology; Medical Director, Mazza Foundation Neuromuscular Program; Director, Muscular Dystrophy Association Clinic

Professor of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Neuromuscular disorders in children with special emphasis on neuroimmunology and autonomic disorders

Specialties, Programs & Conditions

Specialties:

Pediatric Neurology >

Education & Training

Education: Boston University School of Medicine, 1975

Postgraduate Training: Fellowship in clinical electromyography, Mayo Medical School, Rochester, MN, 1982; Fellowship in child neurology, Mayo Graduate School of Medicine, 1977-1980; Residency in pediatrics, Johns Hopkins Hospital, Baltimore, 1975-1977

Board Certifications: General Pediatrics, Neurology with special qualifications in Child Neurology, Neurology with special qualifications in Neurodevelopmental Disabilities

Professional Organizations: American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; Child Neurology Society

Publications

Most recent publications

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial Trials 19 (1): 291
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening J Neuromuscul Dis
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy N Engl J Med 378 (7): 625-635
A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus study Muscle Nerve 57 (4): 550-560
Natural history of infantile-onset spinal muscular atrophy Ann Neurol 82 (6): 883-891
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy N Engl J Med 377 (18): 1723-1732
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy Contemp Clin Trials 58 34-39
Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study Ann Clin Transl Neurol 3 (2): 132-45
Cerebellar mutism in acute disseminating encephalomyelitis Pediatr Neurol 50 (5): 511-4
Spasmodic muscle cramps and weakness as presenting symptoms in Wilson disease Pediatrics 132 (4): e1039-42

Call 1.800.543.7362 for Insurance information. 1.800.543.7362

News

3 Results

Nancy L. Kuntz, MD

Nancy L. Kuntz, MD

Attending Physician, Division of Neurology; Medical Director, Mazza Foundation Neuromuscular Program; Director, Muscular Dystrophy Association Clinic

Professor of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Specialties, Programs & Conditions

Education & Training

Publications

Call 1.800.543.7362 for Insurance information. 1.800.543.7362

News

New Gene Therapy Trial for Severe Neuromuscular Disorder in Children

Drug Improves Muscle Function and Survival in Spinal Muscular Atrophy

Parent Project Muscular Dystrophy Designates Lurie Children’s, a Certified Duchenne Care Center

Nancy L. Kuntz, MD

Nancy L. Kuntz, MD

Attending Physician, Division of Neurology; Medical Director, Mazza Foundation Neuromuscular Program; Director, Muscular Dystrophy Association Clinic

Professor of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Specialties, Programs & Conditions

Education & Training

Publications

Call 1.800.543.7362 for Insurance information. 1.800.543.7362

Locations

News

New Gene Therapy Trial for Severe Neuromuscular Disorder in Children

Drug Improves Muscle Function and Survival in Spinal Muscular Atrophy

Parent Project Muscular Dystrophy Designates Lurie Children’s, a Certified Duchenne Care Center